Yasuo Sekine
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yasuo Sekine has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Eitetsu Koh
Department of Thoracic Surgery, Tokyo Women's Medical University, Yachiyo Medical Center, Yachiyo City, Chiba, Japan
8 shared publicationsAtsushi Hata
Department of Thoracic Surgery, Tokyo Women's Medical University, Yachiyo Medical Center, Yachiyo City, Chiba, Japan
5 shared publicationsKenzo Hiroshima
Department of Pathology, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan
5 shared publicationsMitsuru Yoshino
Department of Thoracic Surgery, Tokyo Women's Medical University, Yachiyo Medical Center
5 shared publicationsHidemi Suzuki
Department of Thoracic Surgery, Chiba University Graduate School of Medicine, Chiba, Japan
4 shared publications- Takehiko Fujisawa
Chiba Foundation for Health Promotion and Disease Prevention
4 shared publications
Latest Publications
- 1 November 2017
- Published by Elsevier in Respiratory Investigation
- Vol. 55 (6) , 365-371
The efficacy of transbronchial needle aspiration with endobronchial ultrasonography using a guide sheath for peripheral pulmonary lesions suspected to be lung cancer
- 1 November 2017
- Published by Elsevier in Respiratory Investigation
- Vol. 55 (6) , 365-371
The efficacy of transbronchial needle aspiration with endobronchial ultrasonography using a guide sheath for peripheral pulmonary lesions suspected to be lung cancer
- 1 January 2016
- Published by Japan Lung Cancer Society in Haigan
- Vol. 56 (2) , 114-118
A Case of Pulmonary Carcinoma with Pulmonary Tuberculosis Diagnosed During Surgery After Induction Chemotherapy
背景.肺癌と肺結核については合併頻度が高いことが示されており,その可能性については常に考慮する必要がある.症例.75歳,男性.左上葉肺腺癌(cT2aN3M0 IIIB)の診断で,導入化学療法(CDDP+PEM 2コース)を施行した.治療効果はPRであり原発巣以外のリンパ節病変はほぼ消失を認め,胸腔鏡下左上葉切除およびリンパ節郭清術を施行した.下葉にも腫瘤を触知し,下葉の部分切除も行った.手術の結果,肺癌はpT2aN1M0 IIAであり,部分切除した腫瘤は結核腫と診断された.術後喀痰でも肺結核と診断され,抗結核薬による治療を行った.化学療法開始前には下葉に腫瘤影を認めず,結核と診断された病変は化学療法後に発症した可能性が示唆された.結論.肺癌と肺結核の合併は頻度が高く,また一方の治療経過中に続発,増悪する可能性もあり得る.合併の際には早急な診断,治療が必要であり,常に念頭に置き診療に当たる必要があると考えられた.
- 1 January 2016
- Published by Japan Lung Cancer Society in Haigan
- Vol. 56 (2) , 114-118
A Case of Pulmonary Carcinoma with Pulmonary Tuberculosis Diagnosed During Surgery After Induction Chemotherapy
背景.肺癌と肺結核については合併頻度が高いことが示されており,その可能性については常に考慮する必要がある.症例.75歳,男性.左上葉肺腺癌(cT2aN3M0 IIIB)の診断で,導入化学療法(CDDP+PEM 2コース)を施行した.治療効果はPRであり原発巣以外のリンパ節病変はほぼ消失を認め,胸腔鏡下左上葉切除およびリンパ節郭清術を施行した.下葉にも腫瘤を触知し,下葉の部分切除も行った.手術の結果,肺癌はpT2aN1M0 IIAであり,部分切除した腫瘤は結核腫と診断された.術後喀痰でも肺結核と診断され,抗結核薬による治療を行った.化学療法開始前には下葉に腫瘤影を認めず,結核と診断された病変は化学療法後に発症した可能性が示唆された.結論.肺癌と肺結核の合併は頻度が高く,また一方の治療経過中に続発,増悪する可能性もあり得る.合併の際には早急な診断,治療が必要であり,常に念頭に置き診療に当たる必要があると考えられた.
- 1 November 2014
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 98 (5) , 1830-1832
Pituitary Apoplexy After Surgical Treatment of Lung Cancer
- 1 November 2014
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 98 (5) , 1830-1832
Pituitary Apoplexy After Surgical Treatment of Lung Cancer
- 1 September 2014
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 98 (3) , 1111-1113
Operative Wound Implantation of Inflammatory Sarcomatoid Carcinoma of the Lung
- 1 September 2014
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 98 (3) , 1111-1113
Operative Wound Implantation of Inflammatory Sarcomatoid Carcinoma of the Lung
- 30 May 2014
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 62 (04) , 332-337
The Impact of Combined Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease on Long-Term Survival after Lung Cancer Surgery
Purpose The purpose of this study was to determine the impact of pulmonary fibrosis (PF) on postoperative complications and on long-term survival after surgical resection in lung cancer patients with chronic obstructive pulmonary disease (COPD). Patients and Methods A retrospective chart review was conducted of 380 patients with COPD who had undergone pulmonary resection for lung cancer at the University Hospital between 1990 and 2005. The definition of COPD was a preoperative forced expiratory volume in 1 second/forced vital capacity (FEV1/FVC) ratio of less than 70%; PF was defined as obvious bilateral fibrous change in the lower lung fields, confirmed by computed tomography. Results PF was present in 41 patients (10.8%) with COPD; the remaining 339 patients (89.2%) did not have PF. The preoperative FVC/FEV1 was significantly lower in the group of patients with PF than in the group without (p < 0.05). Acute lung injury and home oxygen therapy were significantly more common in the PF group; however, the 30-day mortality was similar between the groups. The cumulative survival at 3 and 5 years was 53.6 and 36.9%, respectively, in the PF group and 71.4 and 66.1%, respectively, in the non-PF group (p = 0.0009). Increased age, decreased body mass index, advanced pathologic stage, and the existence of PF were identified as independent risk factors for decreased survival. Conclusion PF is a risk factor for decreased survival after surgical treatment in lung cancer patients with COPD. The Japanese version of this article was published in the official journal of the Japan Lung Cancer Society (Jpn J Lung Cancer 2013;53:7–11) and the permission for the second publication in English was given by this society.
- 30 May 2014
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 62 (04) , 332-337
The Impact of Combined Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease on Long-Term Survival after Lung Cancer Surgery
Purpose The purpose of this study was to determine the impact of pulmonary fibrosis (PF) on postoperative complications and on long-term survival after surgical resection in lung cancer patients with chronic obstructive pulmonary disease (COPD). Patients and Methods A retrospective chart review was conducted of 380 patients with COPD who had undergone pulmonary resection for lung cancer at the University Hospital between 1990 and 2005. The definition of COPD was a preoperative forced expiratory volume in 1 second/forced vital capacity (FEV1/FVC) ratio of less than 70%; PF was defined as obvious bilateral fibrous change in the lower lung fields, confirmed by computed tomography. Results PF was present in 41 patients (10.8%) with COPD; the remaining 339 patients (89.2%) did not have PF. The preoperative FVC/FEV1 was significantly lower in the group of patients with PF than in the group without (p < 0.05). Acute lung injury and home oxygen therapy were significantly more common in the PF group; however, the 30-day mortality was similar between the groups. The cumulative survival at 3 and 5 years was 53.6 and 36.9%, respectively, in the PF group and 71.4 and 66.1%, respectively, in the non-PF group (p = 0.0009). Increased age, decreased body mass index, advanced pathologic stage, and the existence of PF were identified as independent risk factors for decreased survival. Conclusion PF is a risk factor for decreased survival after surgical treatment in lung cancer patients with COPD. The Japanese version of this article was published in the official journal of the Japan Lung Cancer Society (Jpn J Lung Cancer 2013;53:7–11) and the permission for the second publication in English was given by this society.
- 16 April 2014
- Published by Wiley in Respirology
- Vol. 19 (4) , 616
Reply
- 14 March 2014
- Published by Springer Nature in General Thoracic and Cardiovascular Surgery
- Vol. 62 (7) , 415-421
Lung carcinogenesis from chronic obstructive pulmonary disease: characteristics of lung cancer from COPD and contribution of signal transducers and lung stem cells in the inflammatory microenvironment
Chronic obstructive pulmonary disease (COPD) and lung cancer are closely related. The annual incidence of lung cancer arising from COPD has been reported to be 0.8–1.7 %. Treatment of lung cancer from COPD is very difficult due to low cardiopulmonary function, rapid tumor growth, and resistance to molecularly targeted therapies. Chronic inflammation caused by toxic gases can induce COPD and lung cancer. Carcinogenesis in the inflammatory microenvironment occurs during cycles of tissue injury and repair. Cellular damage can induce induction of necrotic cell death and loss of tissue integrity. Quiescent normal stem cells or differentiated progenitor cells are introduced to repair injured tissues. However, inflammatory mediators may promote the growth of bronchioalveolar stem cells, and activation of NF-κB and signal transducer and activator of transcription 3 (STAT3) play crucial roles in the development of lung cancer from COPD. Many of the protumorgenic effects of NF-κB and STAT3 activation in immune cells are mediated through paracrine signaling. NF-κB and STAT3 also contribute to epithelial–mesenchymal transition. To improve lung cancer treatment outcomes, lung cancer from COPD must be overcome. In this article, we review the characteristics of lung cancer from COPD and the mechanisms of carcinogenesis in the inflammatory microenvironment. We also propose the necessity of identifying the mechanisms underlying progression of COPD to lung cancer, and comment on the clinical implications with respect to lung cancer prevention, screening, and therapy.
- 14 March 2014
- Published by Springer Nature in General Thoracic and Cardiovascular Surgery
- Vol. 62 (7) , 415-421
Lung carcinogenesis from chronic obstructive pulmonary disease: characteristics of lung cancer from COPD and contribution of signal transducers and lung stem cells in the inflammatory microenvironment
Chronic obstructive pulmonary disease (COPD) and lung cancer are closely related. The annual incidence of lung cancer arising from COPD has been reported to be 0.8–1.7 %. Treatment of lung cancer from COPD is very difficult due to low cardiopulmonary function, rapid tumor growth, and resistance to molecularly targeted therapies. Chronic inflammation caused by toxic gases can induce COPD and lung cancer. Carcinogenesis in the inflammatory microenvironment occurs during cycles of tissue injury and repair. Cellular damage can induce induction of necrotic cell death and loss of tissue integrity. Quiescent normal stem cells or differentiated progenitor cells are introduced to repair injured tissues. However, inflammatory mediators may promote the growth of bronchioalveolar stem cells, and activation of NF-κB and signal transducer and activator of transcription 3 (STAT3) play crucial roles in the development of lung cancer from COPD. Many of the protumorgenic effects of NF-κB and STAT3 activation in immune cells are mediated through paracrine signaling. NF-κB and STAT3 also contribute to epithelial–mesenchymal transition. To improve lung cancer treatment outcomes, lung cancer from COPD must be overcome. In this article, we review the characteristics of lung cancer from COPD and the mechanisms of carcinogenesis in the inflammatory microenvironment. We also propose the necessity of identifying the mechanisms underlying progression of COPD to lung cancer, and comment on the clinical implications with respect to lung cancer prevention, screening, and therapy.
- Open Access
- 1 January 2014
- Published by Japan Lung Cancer Society in Haigan
- Vol. 54 (6) , 790-794
Pulmonary Granuloma Associated with Non-tuberculous Mycobacteriosis Occurring at the Staple Line After Segmentectomy for Lung Cancer: Report of a Case
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 January 2014
- Published by Japan Lung Cancer Society in Haigan
- Vol. 54 (6) , 790-794
Open AccessPulmonary Granuloma Associated with Non-tuberculous Mycobacteriosis Occurring at the Staple Line After Segmentectomy for Lung Cancer: Report of a Case
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 11 September 2013
- Published by Springer Nature in Surgery Today
- Vol. 44 (11) , 2167-2173
Pericardial synovial sarcoma: a case report and review of the literature
Primary pericardial synovial sarcoma is a rare disease. We herein report a case of synovial sarcoma that originated in the epicardium. A 13-year-old male visited our hospital with a fever and chest pain. Copious pericardial effusion and a large intrapericardial tumor were detected. An open-chest tumor resection was performed. A solid nodular tumor was observed in the pericardial cavity. The tumor was a polypoid mass that was pedunculated and grew from the inner surface of the pericardium near the origin of the SVC and ascending aorta. Histologically, the tumor cells were uniformly spindle shaped, with an ovoid or oval nucleus, and formed solid, compact sheets and fascicles. A storiform pattern was also observed. Based on the histopathological and immunohistochemical findings, and the fluorescence in situ hybridization detection of rearrangement of the SYT gene, a monophasic synovial sarcoma was diagnosed. We discuss the diagnosis and treatment of this case and review the pertinent literature.
- 11 September 2013
- Published by Springer Nature in Surgery Today
- Vol. 44 (11) , 2167-2173
Pericardial synovial sarcoma: a case report and review of the literature
Primary pericardial synovial sarcoma is a rare disease. We herein report a case of synovial sarcoma that originated in the epicardium. A 13-year-old male visited our hospital with a fever and chest pain. Copious pericardial effusion and a large intrapericardial tumor were detected. An open-chest tumor resection was performed. A solid nodular tumor was observed in the pericardial cavity. The tumor was a polypoid mass that was pedunculated and grew from the inner surface of the pericardium near the origin of the SVC and ascending aorta. Histologically, the tumor cells were uniformly spindle shaped, with an ovoid or oval nucleus, and formed solid, compact sheets and fascicles. A storiform pattern was also observed. Based on the histopathological and immunohistochemical findings, and the fluorescence in situ hybridization detection of rearrangement of the SYT gene, a monophasic synovial sarcoma was diagnosed. We discuss the diagnosis and treatment of this case and review the pertinent literature.
- 27 August 2013
- Published by Wiley in Respirology
- Vol. 19 (1) , 98-104
Detection of chronic obstructive pulmonary disease in community‐based annual lung cancer screening: Chiba Chronic Obstructive Pulmonary Disease Lung Cancer Screening Study Group
Background and objective: Detection of chronic obstructive pulmonary disease (COPD) is crucial in the management of COPD. The aim of this study was to establish the utility of a community‐based lung cancer screening for detecting COPD.Methods: In Japan, community‐based lung cancer screening for residents who are 40 years or older using chest radiography is well established. A screening system in Chiba City, Japan, was used to detect COPD. The criteria to consider COPD at screening included age of 60 years or older, a smoking history and chronic respiratory symptoms. Participants fulfilling these criteria were referred for diagnostic evaluation consisting of pulmonary function testing (PFT) and chest computed tomography (CT).Results: Of 89 100 Chiba City residents who underwent lung cancer screening, 72 653 residents were 60 years or older. Among them, 878 (1.0%) were identified with suspected COPD and referred for further evaluation. Of those identified, a total of 567 residents (64.6%, 567/878) underwent further evaluations, and 161 (28.4%) were reported to have COPD, with 38.5% of them requiring COPD treatment. To verify the diagnoses from the secondary evaluation centres, PFT and CT data were collected from 228 study participants, and 24.9% were diagnosed with COPD. CT findings classified according to the Goddard classification revealed that 20.1% of these participants had moderate to severe emphysema.Conclusions: COPD screening added to a community‐based lung cancer screening programme may be effective in the detection of patients with COPD.
- 27 August 2013
- Published by Wiley in Respirology
- Vol. 19 (1) , 98-104
Detection of chronic obstructive pulmonary disease in community‐based annual lung cancer screening: Chiba Chronic Obstructive Pulmonary Disease Lung Cancer Screening Study Group
Background and objective: Detection of chronic obstructive pulmonary disease (COPD) is crucial in the management of COPD. The aim of this study was to establish the utility of a community‐based lung cancer screening for detecting COPD.Methods: In Japan, community‐based lung cancer screening for residents who are 40 years or older using chest radiography is well established. A screening system in Chiba City, Japan, was used to detect COPD. The criteria to consider COPD at screening included age of 60 years or older, a smoking history and chronic respiratory symptoms. Participants fulfilling these criteria were referred for diagnostic evaluation consisting of pulmonary function testing (PFT) and chest computed tomography (CT).Results: Of 89 100 Chiba City residents who underwent lung cancer screening, 72 653 residents were 60 years or older. Among them, 878 (1.0%) were identified with suspected COPD and referred for further evaluation. Of those identified, a total of 567 residents (64.6%, 567/878) underwent further evaluations, and 161 (28.4%) were reported to have COPD, with 38.5% of them requiring COPD treatment. To verify the diagnoses from the secondary evaluation centres, PFT and CT data were collected from 228 study participants, and 24.9% were diagnosed with COPD. CT findings classified according to the Goddard classification revealed that 20.1% of these participants had moderate to severe emphysema.Conclusions: COPD screening added to a community‐based lung cancer screening programme may be effective in the detection of patients with COPD.